Posts

Oramed’s Chinese Partner, HTIT, Successfully Completes Phase 3 Oral Insulin Clinical Trial/Submits Marketing Authorization Application in China
Oramed Pharmaceuticals. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com) strategic partner, Hefei Tianhui Biotechnology (HTIT), has completed its Phase III trials of
Gamida Cell’s Allogeneic Cell Therapy Omisirge® Receives FDA Approval
Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, has recently announced that
VLX Ventures Ventures Launches 4 New Biotech Start-Ups
VLX Ventures has recently announced the launch of 4 new biotech and computational bilgy start-ups, all spearheaded by female CEOs.
Nanox.AI Expands Footprint Through New Global Partnership with Ferrum Health!
NANO-X IMAGING LTD ("Nanox" Nasdaq: NNOX), an innovative medical imaging technology company, announced that its deep-learning medical imaging analytics subsidiary,
Israeli Health Ministry New Platform "Kineret" Providing Real-Time Clinical Data from Israel’s Hospitals
The Directorate of Government Medical Centers at the Ministry of Health has launched a powerful, new resource, Kineret Data Lake, that
Itay&Beyond Raises $2M for Drug Development & Diagnostics for Autistic Spectrum Disorders Groundbreaking Technology
With 2M$ gained through pre-seed funding, Itay&Beyond has initiated the recruitment of 200 low-functioning individuals with Autistic Spectrum Disorder (ASD)
Alpha Tau Launches Alpha DaRT Treatment in Multiple Advanced Cancer Clinical Trials
Jerusalem-based Alpha Tau Medical Ltd. “Alpha Tau”, (NASDAQ: DRTS, DRTSW), has announced that up to 86 patients are to be
BioNTech Heads to Jerusalem to Build mRNA Vax Plant
German biotechnology company BioNTech, which developed the Covid-19 vaccine marketed by Pfizer, will develop the drugs and vaccines using mRNA
Neteera Completes $13 Million Investment Series B Funding Round!
Israeli startup Neteera Technologies, which is headquartered in Jerusalem, has closed their B-round in deteriorating market conditions a $13M round
Gyntools Wins Award at the European Healthtech Investment Forum 2023
Gyntools was showcased at the European Healthtech Investment Forum 2023  in Helsinki, Finland. Among the 41 selected companies from over